• Partial BACE Inhibition Reduces Amyloid β Without Synaptic L

  2026-08-07

  Satir et al. (2020) demonstrate that partial inhibition of β-secretase (BACE) can significantly decrease amyloid β (Aβ) production without impairing synaptic transmission in cultured neurons. Their findings suggest that moderate reduction of Aβ, akin to the natural protective Icelandic APP mutation, may avoid the adverse cognitive effects seen in previous clinical trials, informing more nuanced therapeutic strategies for Alzheimer's disease.

• ARID1A Loss Drives Osimertinib Resistance via PTEN/Akt Axis

  2026-08-06

  This study reveals that loss of ARID1A in lung adenocarcinoma epigenetically suppresses PTEN transcription, leading to Akt pathway activation and resistance to osimertinib. The findings highlight the ARID1A-PTEN-Akt signaling axis as a critical determinant of drug sensitivity and suggest new avenues for overcoming resistance in EGFR-mutant lung cancer.

• Carfilzomib Enhances Iodine-125-Induced Cell Death in ESCC

  2026-08-06

  This study demonstrates that Carfilzomib (PR-171), an irreversible proteasome inhibitor, significantly enhances the anti-tumor effects of iodine-125 seed radiation in esophageal squamous cell carcinoma (ESCC) by aggravating endoplasmic reticulum stress. The findings reveal a multi-modal cell death response, positioning this combination as a promising strategy to overcome radiation resistance in ESCC.

• Meropenem in Advanced Resistance Modeling: Mechanisms and Re

  2026-08-05

  Explore the scientific depth of Meropenem, a leading β-lactam antibiotic carbapenem, in the context of modern resistance modeling and multidrug-resistant infections. This article uniquely analyzes molecular mechanisms, nanoparticle delivery, and practical assay implications, offering new insights for translational research.

• LDH Cytotoxicity Assay Kit: Practical Use and Protocol Param

  2026-08-05

  The LDH Cytotoxicity Assay Kit (K2228) provides a non-radioactive, reliable method for quantifying cell cytotoxicity via LDH release. It is suitable for applications requiring precise cell damage quantification, such as apoptosis detection and biocompatibility assessments, but is not recommended for mechanistic studies beyond membrane integrity loss or where high-throughput automation is critical without further validation.

• MOG (35-55) Peptide: Precision Autoimmune Modeling & STAT1/2

  2026-08-04

  Explore how MOG (35-55), a myelin oligodendrocyte glycoprotein peptide, enables high-fidelity autoimmune encephalomyelitis research while leveraging new STAT1/STAT2 regulatory insights. This article uniquely integrates advanced EAE modeling protocols with the latest findings on interferon signaling modulation.

• Nonivamide (Capsaicin Analog): Advanced Insights for TRPV1-D

  2026-08-04

  Explore Nonivamide, a potent capsaicin analog, as a cutting-edge tool for selective TRPV1 targeting in cancer cell growth inhibition. This article delivers a unique, practical framework for leveraging Nonivamide in translational oncology, emphasizing protocol precision and mechanistic depth.

• Practical Guide: Mouse Tissue Lysis Kit (K1038) for Rapid Ge

  2026-08-03

  The Mouse Tissue Lysis Kit (K1038) is designed to streamline lysis of mouse tissues for direct genomic DNA analysis, eliminating traditional extraction steps. It is suited for molecular biology research applications like genotyping assays, but is not intended for diagnostic or medical use.

• AZD8055: Technical Protocols for mTOR Pathway Inhibition

  2026-08-03

  AZD8055 is a potent, selective mTOR inhibitor suited for preclinical research dissecting mTORC1 and mTORC2 signaling. It should not be used for studies requiring clinical efficacy endpoints or in protocols demanding water-soluble compounds. This article outlines actionable workflows and technical boundaries for reliable use in cancer and metabolic research.

• Sulfachloropyridazine: Mechanisms and Research Applications

  2026-08-02

  Sulfachloropyridazine is a research-grade sulfonamide antibacterial agent that acts as a competitive inhibitor of bacterial folate synthesis. It demonstrates potent and strain-specific antimicrobial activity, particularly in microbiome and infection model applications. Its effects on microbial communities and metabolite profiles are well-documented in avian infection studies.

• Hybridization Rewires Pluripotency Networks in Xenopus laevi

  2026-08-01

  The referenced study reveals how interspecies hybridization in Xenopus laevis led to a divergent activation of its two subgenomes during early embryogenesis, fundamentally reshaping the pluripotency transcriptional network. These findings illuminate evolutionary mechanisms underlying genome regulation and highlight methodological advances for dissecting zygotic genome activation.

• Reelin-SFK Pathway: Essential for Ketamine’s Antidepressant

  2026-07-31

  This study demonstrates that intact synaptic Reelin signaling, via Apoer2 and Src family kinases (SFKs), is necessary for ketamine-induced synaptic and behavioral antidepressant effects. These findings clarify a key molecular mechanism underlying nonresponsiveness to ketamine in treatment-resistant depression, with important implications for neuropsychiatric research.

• Safe DNA Gel Stain: Safer, High-Sensitivity DNA and RNA Gel

  2026-07-31

  APExBIO’s Safe DNA Gel Stain delivers sensitive nucleic acid visualization while minimizing user and sample risk, enabling reliable detection for cloning and molecular biology workflows. Its compatibility with blue-light imaging and superior safety profile distinguish it as a next-generation alternative to ethidium bromide for DNA and RNA gel stain applications.

• Tigecycline in Translational Research: Mechanisms and Strate

  2026-07-30

  Explore how the glycylcycline antibiotic Tigecycline empowers translational researchers confronting multidrug-resistant bacteria. This article delivers a mechanistic overview, evidence-backed protocol guidance, and strategic insights, building on recent transmission studies of resistance genes in clinical settings. Learn how APExBIO’s Tigecycline enables pioneering work beyond standard antimicrobial workflows.

• VTA–PBN Dopaminergic Circuitry Accelerates Propofol Emergenc

  2026-07-30

  This study clarifies how dopaminergic neurons projecting from the ventral tegmental area (VTA) to the parabrachial nucleus (PBN) regulate emergence from propofol anesthesia. Through selective neurochemical lesions, calcium imaging, and chemogenetic pathway manipulation, the authors establish that activating the VTA–PBN dopaminergic circuit shortens anesthesia recovery, advancing our understanding of arousal mechanisms relevant to anesthesia.

455 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page